Pharma channel feed

Broad In­sti­tute opens new $300M cen­ter to an­swer 1 ques­tion: What's pos­si­ble when you ap­ply ma­chine learn­ing to bi­ol­o­gy?

5 years ago

US to no longer dis­trib­ute Eli Lil­ly’s bam­lanivimab alone due to coro­n­avirus vari­ants

5 years ago
FDA+
Coronavirus

HHS in­spec­tor gen­er­al signs off on No­var­tis pay­ing for pricey Kym­ri­ah

5 years ago
FDA+

Bris­tol My­ers Squibb out­races the pack to a late-stage tri­al win for its LAG-3/PD-1 an­ti­body com­bo in melanoma

5 years ago
R&D

FDA adds Guil­lain-Bar­ré syn­drome warn­ing to Glax­o­SmithK­line’s shin­gles vac­cine

5 years ago
FDA+

Te­va sees room for growth with FDA com­mu­ni­ca­tions and com­plex gener­ics, COO says

5 years ago
FDA+

Ab­b­Vie ac­cus­es ri­val of steal­ing block­buster ‘trade se­crets’ as clock ticks down on biosim­i­lar as­sault

5 years ago

Tougher reg­u­la­to­ry en­vi­ron­ment for bio­phar­ma? De­bate en­sues

5 years ago
FDA+

Pfiz­er emerges from pan­dem­ic cru­cible with con­fi­dence to go so­lo in tak­ing mR­NA vac­cines be­yond Covid-19

5 years ago
Coronavirus

‘A mess across the board’: Sen­ate com­mit­tee kicks off talks on drug pric­ing re­forms

5 years ago
FDA+

With at least one gas­tric can­cer ap­proval on the line, Mer­ck­'s Keytru­da scores nod for ear­ly pa­tients in chemo com­bo

5 years ago
FDA+

Mid­dle-of-the-night NIH state­ment rais­es con­cerns on As­traZeneca's US vac­cine tri­al read­out

5 years ago
Coronavirus

Re­gen­eron to seek EUA for low­er dose of Covid-19 mAb cock­tail as new tri­al shows ma­jor drop in risk of hos­pi­tal­iza­tion or death

5 years ago
Coronavirus

Pfiz­er has run 41 tri­als over 15 years for tanezum­ab. As ad­comm nears, the FDA re­mains unim­pressed — and more than a lit­tle wor­ried

5 years ago
FDA+

PhRMA at­tacks New Mex­i­co’s ‘short on de­tail’ plan for Cana­di­an drug im­ports

5 years ago
FDA+

Roche claims key win in the $12B ear­ly-stage check­point race

5 years ago
R&D

A packed MS mar­ket is about to get busier as J&J's pones­i­mod en­ters the fray

5 years ago
FDA+

Mer­ck breathes a sigh of re­lief as Keytru­da-Lenvi­ma com­bo aces con­fir­ma­to­ry study in en­dome­tri­al can­cer

5 years ago
R&D

Drug­mak­ers brace for a pric­ing fight as Xavier Be­cer­ra is con­firmed as the next HHS sec­re­tary

5 years ago
People

Eu­rope mulls halt­ing Covid-19 vac­cine ex­ports to some coun­tries

5 years ago
FDA+

Court win for Eli Lil­ly halts HHS’s drug dis­count rule

5 years ago
FDA+

FTC pledges to ag­gres­sive­ly crack down on phar­ma merg­ers

5 years ago
FDA+

Eli Lil­ly's IL-23 in­hibitor mirik­izum­ab shows late-stage promise in ul­cer­a­tive col­i­tis — but Ab­b­Vie's Skyrizi looms

5 years ago
R&D

BIO chair slams Trump’s HHS, calls to stop Russ­ian dis­in­for­ma­tion cam­paign on vac­cines

5 years ago
People
First page Previous page 244245246247248249250 Next page Last page
A service from the Financial Times